Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

por Wagner, Nikolaus B., Weide, Benjamin, Gries, Mirko, Reith, Maike, Tarnanidis, Kathrin, Schuermans, Valerie, Kemper, Charlotte, Kehrel, Coretta, Funder, Anne, Lichtenberger, Ramtin, Sucker, Antje, Herpel, Esther, Holland-Letz, Tim, Schadendorf, Dirk, Garbe, Claus, Umansky, Viktor, Utikal, Jochen, Gebhardt, Christoffer
Publicado 2019